Nine new research grants from the USA's National Center for Complementary and Integrative Health (NCCIH) will fund investigations into the potential pain-relieving properties of...

A cannabis-based formulation developed by Australia's CannPal (ASX:CP1) has substantially reduced atopic dermatitis severity in dogs participating in clinical trial.Atopic dermatitis is triggered by...

A genetically engineered (GE) hemp variety modified to produce no tetrahydrocannabinol (THC) and cannabidiol (CBD) has cleared a regulatory hurdle in the USA.In the...

Celadon Pharmaceuticals Plc announced last week that it has been approved to commence a unique non-cancer chronic pain clinical trial for up to 5,000...